Nu-Med Plus (NUMD) Net Equity Issued and Repurchased (2012 - 2021)
Nu-Med Plus (NUMD) reported Net Equity Issued and Repurchased of $30000.0 for Q1 2021, down 85.0% sequentially from $200000.0 in Q4 2020.
Nu-Med Plus (NUMD) Net Equity Issued and Repurchased (2012 - 2021) Analysis & Trends
Nu-Med Plus (NUMD) has 9 years of Net Equity Issued and Repurchased data on file, last reported at $30000.0 in Q1 2021.
- For the quarter ending Q1 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $30000.0; the trailing twelve-month figure through Dec 2021 stood at $30000.0 (down 89.47% YoY), and the FY2021 full-year result was $30000.0, down 85.0% from the prior year.
- Net Equity Issued and Repurchased eased to $30000.0 in Q1 2021, from $200000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $665700.0 in Q3 2017 to a low of -$729705.0 in Q4 2017.
- A 4-year average of $120270.0 and a median of $97500.0 in 2018 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 26528.0% in 2017, while the deepest fall reached 581.97% in 2017.
- Tracing NUMD's Net Equity Issued and Repurchased over 4 years: stood at -$729705.0 in 2017, then jumped by 111.65% to $85000.0 in 2018, then jumped by 135.29% to $200000.0 in 2020, then sank by 85.0% to $30000.0 in 2021.
- Business Quant data shows NUMD's Net Equity Issued and Repurchased at $30000.0 in Q1 2021, $200000.0 in Q4 2020, and $85000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 30,000.00 |
| Mar 31, 2021 | 30,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2018 | 85,000.00 |
| Dec 31, 2018 | 85,000.00 |
| Sep 30, 2018 | 110,000.00 |
| Sep 30, 2018 | 110,000.00 |
| Jun 30, 2018 | -8,220.00 |
| Jun 30, 2018 | -8,220.00 |
| Mar 31, 2018 | 8,220.00 |
| Mar 31, 2018 | 8,220.00 |
| Dec 31, 2017 | -729,705.00 |
| Dec 31, 2017 | -729,705.00 |
| Sep 30, 2017 | 665,700.00 |
| Sep 30, 2017 | 665,700.00 |
| Jun 30, 2017 | 435,205.00 |
| Jun 30, 2017 | 435,205.00 |
| Mar 31, 2017 | 406,500.00 |
| Mar 31, 2017 | 406,500.00 |